The German parliament has approved a billion-euro “future fund” to help fledgling companies expand their business.

US investor interest in Germany remains strong, with companies in a range of innovative sectors establishing operations in the country.

German pharmaceutical company BioNTech and Pfizer have presented the first results of their phase 3 study to develop a Covid-19 vaccine that should provide more than 90 percent protection.

Record R&D spending in 2019 puts the country among the world leaders in research spending – with the trend set to continue in the crisis year 2020.

Germany’s automotive sector is recovering from the corona sales slump of the first three quarters of 2020 – with Germans buying more electric, premium and sport utility vehicles.

Germany’s automotive sector has turned the coronavirus corner, with premium brand sales helping auto giants return to operating profit.

Germany's food and beverage sector is continuing to attract major international companies - in some cases as a result of the Covid-19 crisis.

In an extended press conference after the government announced a four-week temporary lockdown, Peter Altmaier offered reassuring words about its negative economic impact.

In response to rising Covid-19 infection figures in Germany and across Europe, the federal German government and the sixteen regional German states have imposed a number of new restrictions, effective from November 2 until the end of the month.

There are currently 97 Covid-19 clinical studies registered in Germany, almost half of which are international studies - underlining Germany's leading role in global research for Covid-19 treatment.